These range from neuromuscular, skeletal, and kidney disorders caused by loss-of-function of PIP phosphatases (e.g., myotubularin family members, FIG4, OCRL) to overgrowth syndrome, immune deficiency, and cancer as a result of hyperactivation of the class I PI3K/AKT signaling pathway. Here, AKT1 is linked to cancer.